Valeo Pharma Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Valeo Pharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10911
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Valeo Pharma Inc (Valeo Pharma), a subsidiary of Manitex Capital Inc, is a pharmaceutical company that offers healthcare solutions and specialty products. The company provides dermatology products such as drops, tablets, solutions, injections among others. It develops, licenses, and commercializes products in dermatology and other specialty therapeutic areas such as oncology, neurodegenerative diseases, rare and orphan diseases, pain management, including narcotics, and others. Valeo Pharma provides Synacthen indications such as rheumatoid arthritis, psoriatic arthritis, bell’s palsy, acute exacerbations, ulcerative colitis, adjuvant treatment in cases of acute gout, lupus erythematosus, nephrotic syndrome and scleroderma. The company seeks to work in partnership with other pharmaceutical companies and research centers. Valeo Pharma is headquartered in Kirkland, Quebec, Canada.

Valeo Pharma Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Valeo Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Valeo Pharma and Besins Healthcare Enter into Agreement 10
Zambon Enters into Agreement with Valeo Pharma 11
Valeo Pharma Enters into Distribution Agreement with Questcor Pharma for Synacthen Depot 12
Asset Transactions 13
Valeant Canada Acquires Dermatology Products from Valeo Pharma for USD23 Million 13
Valeo Pharma Inc – Key Competitors 14
Valeo Pharma Inc – Key Employees 15
Valeo Pharma Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Legal and Regulatory 17
Oct 01, 2018: Manitex Capital announces that its affiliate Valeo Pharma has filed a non-offering preliminary prospectus 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Key Facts 2
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Valeo Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Valeo Pharma Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Valeo Pharma and Besins Healthcare Enter into Agreement 10
Zambon Enters into Agreement with Valeo Pharma 11
Valeo Pharma Enters into Distribution Agreement with Questcor Pharma for Synacthen Depot 12
Valeant Canada Acquires Dermatology Products from Valeo Pharma for USD23 Million 13
Valeo Pharma Inc, Key Competitors 14
Valeo Pharma Inc, Key Employees 15

List of Figures
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Valeo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Valeo Pharma Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Overture Networks, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Overture Networks, Inc. Mergers …
  • Med Discovery SA:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Med Discovery SA Mergers and Ac …
  • Verlagsgesellschaft Madsack GmbH and Co. KG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Verlagsgesellschaft Madsack Gmb …
  • Medical & Biological Laboratories Co Ltd (4557):企業のM&A・提携動向(医療機器分野)
    Summary Medical & Biological Laboratories Co Ltd (MBL) is a biotechnology company that develops and manufactures clinical diagnostics and basic laboratory diagnostics. The company’s products comprise research reagents, diagnostic reagents and companion diagnostics. It provides diagnostic reagents fo …
  • Simple S.A. (SME):企業財務及び戦略的SWOT分析
    Summary Simple S.A. (Simple) is an information technology company that develops software solutions. The company offers product such as programming solutions include SIMPLE.APS, SIMPLE.CRM, SIMPLE.ERP, SIMPLE.SPRINT, SIMPLE.HCM, and SIMPLE.WMS, among others. Its services include implementing, integra …
  • Bang and Olufsen A/S:企業の戦略・SWOT・財務分析
    SummaryBang and Olufsen A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fi …
  • OXEA Group:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' OXEA Group Mergers and Acquisit …
  • Woongjin Coway Co., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Woongjin Coway Co., Ltd. Merger …
  • Enersis S.A. (ENERSIS):企業のM&A・提携動向(エネルギー分野)
    Summary Enersis S.A. (Enersis) is an integrated electricity utility in Latin America. The group through its subsidiaries and affiliates carries out the generation, transmission and distribution of electricity in Argentina, Brazil, Chile, Colombia and Peru. It operates electricity generation units wi …
  • Midmark Corporation:(医療機器分野)企業M&A及び提携動向
    Summary Midmark Corporation (Midmark) is a healthcare product manufacturer. The company manufactures and supplies medical, dental and veterinary healthcare equipment solutions. Its medical products and services include power procedures tables and chairs, power examination tables, manual examination …
  • InTouch Technologies Inc:企業の戦略的SWOT分析
    InTouch Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Li3 Energy, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Li3 Energy, Inc. Mergers and Ac …
  • Intematix Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Intematix Corporation Mergers a …
  • Presbia Plc (LENS):医療機器:M&Aディール及び事業提携情報
    Summary Presbia Plc (Presbia) is a medical device company. The company develops presbyopia-correcting presbia flexivue microlens, a solutions for the age-related loss of the ability to read or focus on near objects. Its microlens helps people to read newspapers, restaurant menus, cell phone messages …
  • Etron Technology, Inc. (5351):企業財務及び戦略的SWOT分析
    Summary Etron Technology, Inc. (Etron), a subsidiary of Hong Tai Electric Industrial Co., Ltd. is an electronic equipment company that offers semiconductor equipment. The company specializes in buffer memory and system-on-chips. It offers products such as memory ICs and system ICs. Etron’s memory IC …
  • Maoming Petro-Chemical Shihua Co., Ltd. (000637):企業の財務及び戦略的SWOT分析
    Summary Maoming Petro-Chemical Shihua Co., Ltd. (Maoming) is a chemical company that manufactures and markets petrochemicals. The company’s products include polypropylene resin powder, sec-butyl acetate, methyl tert-butyl ether, amine, aromatic solvent oil, petroleum gas products, industrial white a …
  • DTS Corporation (9682):企業の財務及び戦略的SWOT分析
    Summary DTS Corporation (DTS) is an information technology service provider company that offers systems integration and information services. The company’s services include system integration, development, maintenance of information system, designs, execution of electrical and telecommunications con …
  • Towers Watson and Co.:企業の戦略・SWOT・財務分析
    SummaryTowers Watson and Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key F …
  • Novadaq Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Novadaq Technologies Inc (Novadaq) is a medical imaging company. It develops, manufactures and markets real-time fluorescence imaging technology products. The company’s SPY Imaging Technology products include SPY Elite open surgical imaging system, PinPoint endoscopic fluorescence imaging sy …
  • BD Biosciences(製薬・医療分野):企業M&A動向
    Summary BD Biosciences (BD) provides instruments, reagents and cell culture products. Its instruments include cell analyzers, cell sorters and software. BD’s reagents include buffers, cell-based assays, bioimaging reagents, multicolor cocktails, ASR reagents, purified antibodies, and single-color an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆